Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 19, 2003 03:39 ET | Source: Innogenetics

Innogenetics Reports Results for the First Half of 2003 in Line with Expectations

GENT, Belgium, Aug. 19, 2003 (PRIMEZONE) -- Innogenetics (Other OTC:INGTF) today announced its unaudited results for the first half ending June 30, 2003. First half 2003 highlights (versus first...
May 15, 2003 03:53 ET | Source: Innogenetics

Innogenetics Reports Results for the First Quarter of 2003 in Line with Expectations

GENT, Belgium, May 15, 2003 (PRIMEZONE) -- Innogenetics today announced its results for the first quarter ending March 31, 2003. First quarter 2003 highlights (versus first quarter 2002) -...
May 06, 2003 02:45 ET | Source: Innogenetics

Innogenetics Announces Positive Results in Pivotal Preclinical Study in Sepsis

GENT, Belgium, May 6, 2003 (PRIMEZONE) -- Innogenetics (Other OTC:INGTF) today reported the results of its pivotal preclinical evaluation of a proprietary anti-inflammatory monoclonal antibody, INNO...
January 15, 2003 02:21 ET | Source: Innogenetics

Innogenetics' Outlook for 2003 -- Enhanced Financial Prospects and Promising New Therapeutic Developments

GENT, Belgium, Jan. 15, 2003 (PRIMEZONE) -- Innogenetics (Other OTC:INGTF) today announced the preliminary indications of its year 2002 financial results, offered an initial outlook for 2003 and...
November 15, 2002 04:09 ET | Source: Innogenetics

Innogenetics Reports Profitable Diagnostics Activities and Increased R&D Investments for the First Nine Months of 2002

GENT, Belgium, Nov. 15, 2002 (PRIMEZONE) -- Innogenetics (Other OTC:INGTF) today announced its results for the first nine months ending September 30, 2002. Highlights -- Diagnostics Division...
October 17, 2002 03:51 ET | Source: Innogenetics

Innogenetics Announces Positive Liver Histology Results of Its Hepatitis C Therapeutic Vaccine

GENT, Belgium, Oct. 17, 2002 (PRIMEZONE) -- Innogenetics (Other OTC:INGTF) today announced the first liver histology results of its E1-based therapeutic candidate vaccine in 24 patients chronically...